Candidiasis
📧 Sign up to get email alerts when something new happens for Candidiasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants [Phase 4]
Phase 4 clinical trial comparing two prophylactic treatments to prevent invasive fungal infections in liver transplant recipients has comple…
-
FDA approval · 2010-03-05FDA Approved: AMPHOTERICIN B — Supplemental Application (XGen Pharmaceuticals DJB, Inc.)
FDA approved a supplemental application for Amphotericin B submitted by XGen Pharmaceuticals DJB, Inc. This approval authorizes a change to …
-
FDA approval · 2009-12-03FDA Approved: NYSTATIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved a supplemental application for NYSTATIN from Padagis Israel Pharmaceuticals Ltd.
-
FDA approval · 2009-09-18FDA Approved: FLUCONAZOLE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for fluconazole from Rising Pharma Holdings, Inc., enabling the generic antifungal to enter the market…
-
EMA withdrawal · 2009-08-04EMA Lapsed: Posaconazole SP (posaconazole) — Schering-Plough Europe
EMA status shows Posaconazole SP has lapsed; therapeutic areas include candidiasis, mycoses, coccidioidomycosis, and aspergillosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-07-30FDA Approved: FLUCONAZOLE — Original Application (Hospira, Inc)
FDA approved Hospira's original application for a generic fluconazole product, an antifungal medication with indications similar to the refe…
-
CLINICAL_TRIALS trial_result · 2009-05-13Clinical Trial Update: Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection
This completed clinical trial assesses caspofungin acetate (Cancidas) for treating candidiasis and aspergillosis.
-
CLINICAL_TRIALS trial_result · 2009-04-28Clinical Trial Update: Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis [Phase 3]
This entry reports a Phase 3 clinical trial evaluating the efficacy, tolerability, and safety of a clindamycin and ketoconazole combination …
-
FDA approval · 2009-04-17FDA Approved: NYSTATIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for NYSTATIN submitted by Padagis Israel Pharmaceuticals Ltd. The action confirms approval of the su…
-
CLINICAL_TRIALS trial_result · 2008-10-20Clinical Trial Update: The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC) [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of intravenous anidulafungin for azole-refractory mucosal candidiasis (FRMC). The …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients [Phase 3]
A Phase 3 trial comparing fluconazole with FK463 to prevent fungal infections in bone marrow transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections [Phase 3]
Open-label Phase III multicenter trial evaluating voriconazole for invasive fungal infections has completed. The study assessed efficacy, sa…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units [Phase 3]
A Phase 3 trial evaluating caspofungin to prevent candidiasis in adults in hospital ICU settings has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Voriconazole to Prevent Systemic Fungal Infections in Children [Phase 1]
This Phase 1 trial evaluates voriconazole for the prevention of systemic fungal infections in pediatric patients.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Fluconazole Prophylaxis of Thrush in AIDS [Phase 4]
This update reports the completion of a Phase 4 trial evaluating fluconazole as prophylaxis against thrush in people with AIDS. The study fo…
-
FDA approval · 2007-09-10FDA Approved: CLOTRIMAZOLE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for clotrimazole by Padagis US LLC.
-
FDA approval · 2007-09-04FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for a generic topical product combining nystatin and triamcinolone acetonide (Sun Pharmaceutical…
-
FDA approval · 2007-04-30FDA Approved: BASIC CARE TIOCONAZOLE — Supplemental Application (Amazon.com Services LLC)
FDA supplemental approval for Basic Care Tioconazole (tioconazole) to the Amazon.com Services LLC's ANDA075915 product, authorizing continue…
-
EMA withdrawal · 2007-03-21EMA Refused: Mycograb (recombinant human monoclonal antibody to hsp) — NeuTec Pharma plc
EMA refused authorization for Mycograb, a recombinant human monoclonal antibody targeting hsp for candidiasis, by NeuTec Pharma plc.
-
FDA approval · 2006-09-15FDA Approved: NOXAFIL — Original Application (Merck Sharp & Dohme LLC)
NOXAFIL (posaconazole) received FDA approval through its original application as a broad-spectrum antifungal agent for the prevention of inv…
-
FDA label_change · 2006-05-19FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for VFEND (voriconazole) submitted by Roerig, updating the product labeling.